NATH BIO (India) Performance

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:3em;padding-top: 40px;;'>NAT</div>
The corporation secures Beta (Market Risk) of 0.0 which conveys that the returns on MARKET and NATH BIO are completely uncorrelated. Although it is extremely important to respect NATH BIO GENES price patterns, it is better to be realistic regarding the information on equity historical price patterns. The approach into estimating future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By inspecting NATH BIO GENES technical indicators you can now evaluate if the expected return of 0.0% will be sustainable into the future. NATH BIO GENES currently secures a risk of 0.0%. Please verify NATH BIO GENES IN Maximum Drawdown as well as the relationship between Downside Variance and Skewness to decide if NATH BIO GENES IN will be following its current price movements.

Risk-Adjusted Performance

Over the last 30 days NATH BIO GENES IN has generated negative risk-adjusted returns adding no value to investors with long positions. Allthough quite persistent forward indicators, NATH BIO is not utilizing all of its potentials. The current stock price mess, may contribute to short term losses for the partners.

NATH BIO GENES Relative Risk vs. Return Landscape

If you would invest  0.00  in NATH BIO GENES IN on January 24, 2020 and sell it today you would earn a total of  0.00  from holding NATH BIO GENES IN or generate 0.0% return on investment over 30 days. NATH BIO GENES IN is generating negative expected returns and assumes 0.0% volatility on return distribution over the 30 days horizon. Simply put, 0% of equities are less volatile than NATH BIO and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
  Risk (%) 

NATH BIO Market Risk Analysis

Sharpe Ratio = 0.0
Good Returns
Average Returns
Small Returns
Based on monthly moving average NATH BIO is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NATH BIO by adding it to a well-diversified portfolio.


Equity Alerts and Improvement Suggestions

NATH BIO GENES is not yet fully synchronised with the market data
NATH BIO GENES has some characteristics of a very speculative penny stock
N/A has accumulated about 76.92 M in cash with (141.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.81.
Check out Stocks Correlation. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Company logos by clearbit